Proteomics and islet research.
The complementary disciplines of genomics and proteomics offer better insights into the molecular mechanisms of diseases. While genomics hunts for defining our static genetic substrate, proteomics explores the structure and function of proteins expressed by a cell or tissue type under specified conditions. In the past decade, proteomics has been revolutionized by the application of techniques such as two-dimensional gel electrophoresis (2DGE), mass spectrometry (MS), and protein arrays. These techniques have tremendous potential for biomarker development, target validation, diagnosis, prognosis, and optimization of treatment in medical care, especially in the field of islet and diabetes research. This chapter will highlight the contributions of proteomic technologies toward the dissection of complex network of signaling molecules regulating islet function, the identification of potential biomarkers, and the understanding of mechanisms involved in the pathogenesis of diabetes.
Ahmed
Meftun
M
Department of Physiology, Ibrahim Medical College, University of Dhaka, Dhaka, Bangladesh. meftun@hotmail.com
D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D014408:Biomarkers, Tumor / Q000032:analysis; D019295:Computational Biology / Q000379:methods; D003920:Diabetes Mellitus / Q000378:metabolism; D015180:Electrophoresis, Gel, Two-Dimensional; D023281:Genomics; D006801:Humans; D007515:Islets of Langerhans / Q000166:cytology* / Q000378:metabolism; D013058:Mass Spectrometry / Q000379:methods; D040081:Protein Array Analysis; D020543:Proteome; D040901:Proteomics / Q000379:methods*
D015415:Biomarkers; D014408:Biomarkers, Tumor; D020543:Proteome